Mirum Pharmaceuticals, Inc.
MIRM
$100.64
$1.871.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -67.23M | -790.16M | -5.73M | 2.91M | -5.86M |
| Total Depreciation and Amortization | 6.94M | 6.87M | 6.07M | 6.06M | 6.06M |
| Total Amortization of Deferred Charges | 658.00K | 454.00K | 436.00K | 443.00K | 427.00K |
| Total Other Non-Cash Items | 55.60M | 451.85M | 19.29M | 18.13M | 17.97M |
| Change in Net Operating Assets | -40.22M | 102.22M | -14.01M | 12.15M | -6.56M |
| Cash from Operations | -44.25M | -228.76M | 6.07M | 39.68M | 12.04M |
| Capital Expenditure | -23.00K | -664.00K | -600.00K | -187.00K | -126.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -159.97M | -10.91M | 1.61M | -2.04M | -6.47M |
| Cash from Investing | -159.99M | -11.57M | 1.01M | -2.23M | -6.60M |
| Total Debt Issued | 672.44M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.77M | 278.68M | 9.00M | 16.10M | 8.69M |
| Repurchase of Common Stock | -474.37M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.60M | -8.60M | -- | -- | -- |
| Cash from Financing | 211.44M | 270.08M | 9.00M | 16.10M | 8.69M |
| Foreign Exchange rate Adjustments | -1.37M | -1.27M | -408.00K | 349.00K | 2.23M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.82M | 28.48M | 15.66M | 53.90M | 16.36M |